Table of Content

1 INTRODUCTION 
    1.1 OBJECTIVES OF THE STUDY 
    1.2 MARKET DEFINITION 
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY 
    1.5 STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
    1.7 RECESSION IMPACT 
2 RESEARCH METHODOLOGY 
    2.1 RESEARCH DATA 
    2.2 PRIMARY SOURCES 
    2.3 MARKET SIZE ESTIMATION METHODOLOGY 
    2.4 MARKET ESTIMATION 
    2.5 MARKET DATA ESTIMATION AND TRIANGULATION 
    2.6 RESEARCH ASSUMPTIONS  
    2.7 RISK ASSESSMENT 
    2.8 RESEARCH LIMITATIONS 
           2.8.1 METHODOLOGY-RELATED LIMITATIONS 
           2.8.2 SCOPE-RELATED LIMITATIONS 
    2.9 RECESSION IMPACT 
3 EXECUTIVE SUMMARY 
4 PREMIUM INSIGHTS 
5 MARKET OVERVIEW 
    5.1 MARKET DYNAMICS  
           5.1.1 DRIVERS 
           5.1.2 RESTRAINTS 
           5.1.3 OPPORTUNITIES 
           5.1.4 CHALLENGES 
    5.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
    5.3 INDUSTRY TRENDS 
           5.3.1 ROLE OF MHEALTH IN PATIENT ENGAGEMENT 
           5.3.2 INCREASING ADOPTION OF TELEMEDICINE 
           5.3.3 SMART HOSPITAL ROOMS WITH BEDSIDE TABLETS
    5.4 ECOSYSTEM ANALYSIS 
    5.5 VALUE CHAIN ANALYSIS 
    5.6 TECHNOLOGY ANALYSIS  
           5.6.1 ARTIFICIAL INTELLIGENCE (AI) CHATBOTS
           5.6.2 WEARABLE DEVICES
    5.7 TARIFF AND REGULATORY LANDSCAPE  
           5.7.1 TARIFF RELATED TO PATIENT ENGAGEMENT SOLUTIONS
           5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 
           5.7.3 REGULATORY ANALYSIS 
                    5.7.3.1 North America 
                               5.7.3.1.1 US 
                               5.7.3.1.2 Canada 
                    5.7.3.2 Europe 
                    5.7.3.3 Asia Pacific 
                               5.7.2.3.1 Japan 
                               5.7.3.3.2 China 
                               5.7.3.3.3 India 
                    5.7.3.4 Latin America 
    5.8 PRICING ANALYSIS 
           5.8.1 PRICING OVERVIEW
           5.8.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT 
           5.8.3 AVERAGE SELLING PRICE TREND, BY REGION 
    5.9 TRADE ANALYSIS 
    5.10 PORTER’S FIVE FORCES ANALYSIS 
    5.11 PATENT ANALYSIS 
    5.12 KEY STAKEHOLDERS AND BUYING CRITERIA  
           5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 
           5.12.2 BUYING CRITERIA 
    5.13 END USER ANALYSIS 
           5.13.1 UNMET NEEDS
           5.13.2 END USER EXPECTATIONS 
    5.14 KEY CONFERENCES & EVENTS IN 2023-2024 
    5.15 REPLACEMENT TRENDS FOR PATIENT ENGAGEMENT SOLUTIONS 
    5.16 PATIENT ENGAGEMENT SOLUTIONS INVESTMENT LANDSCAPE 
    5.17 USE CASES/CASE STUDIES 
6 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT 
    6.1 INTRODUCTION 
    6.2 HARDWARE 
           6.2.1 IN-ROOM TELEVISIONS
           6.2.2 INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES
           6.2.3 TABLETS
    6.3 SOFTWARE 
           6.3.1 STANDALONE SOFTWARE
           6.3.2 INTEGRATED SOFTWARE
    6.4 SERVICES 
7 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE 
    7.1 INTRODUCTION 
    7.2 ON-PREMISE MODE 
    7.3 CLOUD-BASED/WEB-BASED MODE 
8 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION 
    8.1 INTRODUCTION 
    8.2 HEALTH MANAGEMENT 
    8.3 HOME HEALTH MANAGEMENT 
    8.4 SOCIAL & BEHAVIORAL MANAGEMENT 
    8.5 FINANCIAL HEALTH MANAGEMENT 
9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA 
    9.1 INTRODUCTION 
    9.2 CHRONIC DISEASES 
           9.2.1 CARDIOVASCULAR DISEASES (CVD)
           9.2.2 DIABETES
           9.2.3 OBESITY
           9.2.4 OTHER CHRONIC DISEASES
    9.3 WOMEN’S HEALTH 
    9.4 FITNESS/HEALTH & WELLNESS 
    9.5 OTHER THERAPEUTIC AREAS 
10 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY 
     10.1 INTRODUCTION 
             10.1.1 E-PRESCRIBING
             10.1.2 TELEHEALTH
             10.1.3 PATIENT/CLIENT SCHEDULING
             10.1.4 DOCUMENT MANAGEMENT
             10.1.5 PATIENT EDUCATION
             10.1.6 BILLING & PAYMENTS
             10.1.7 OTHERS (COMMUNICATION, HEALTH TRACKING & INSIGHTS)

11 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER 
     11.1 INTRODUCTION 
     11.2 PROVIDERS 
             11.2.1 HOSPITALS AND HEALTHCARE SYSTEM
             11.2.2 AMBULATORY CARE CENTERS
             11.2.3 HOME HEALTHCARE
             11.2.3 OTHERS (LONG TERM CARE FACILITIES, REHABILITATION CENTERS, NURSING HOME, ASSISTED LIVING FACILITIES)
     11.3 PAYERS 
             11.3.1 PRIVATE
             11.3.2 PUBLIC
     11.4 PATIENTS 
     11.5 OTHER END USERS 
12 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION  
     12.1 INTRODUCTION  
     12.2 NORTH AMERICA  
             12.2.1 US 
             12.2.2 CANADA 
             12.2.3 NORTH AMERICA: IMPACT OF ECONOMIC RECESSION
     12.3 EUROPE  
             12.3.1 GERMANY 
             12.3.2 FRANCE 
             12.3.3 UK 
             12.3.4 ITALY 
             12.3.5 SPAIN 
             12.3.6 REST OF EUROPE 
             12.3.7  EUROPE: IMPACT OF ECONOMIC RECESSION
     12.4 ASIA PACIFIC  
             12.4.1 CHINA 
             12.4.2 JAPAN 
             12.4.3 INDIA 
             12.4.3 REST OF ASIA PACIFIC
             12.4.5 ASIA PACIFIC: IMPACT OF ECONOMIC RECESSION
     12.5 LATIN AMERICA  
             12.5.1 BRAZIL
             12.5.2 MEXICO
             12.5.3 REST OF LATIN AMERICA
             12.5.4 LATIN AMERICA: IMPACT OF ECONOMIC RECESSION
     12.6 MIDDLE EAST AND AFRICA  
             12.6.1 GCC COUNTRIES
             12.6.2 REST OF MIDDLE EAST & AFRICA
             12.6.3 MIDDLE EAST & AFRICA: IMPACT OF ECONOMIC RECESSION
13 COMPETITIVE LANDSCAPE  
     13.1 OVERVIEW  
     13.2 STRATEGIES ADOPTED BY KEY PLAYERS  
     13.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS  
     13.4 MARKET SHARE/RANKING ANALYSIS  
     13.5 COMPANY EVALUATION MATRIX 
             13.5.1 STARS 
             13.5.2 EMERGING LEADERS 
             13.5.3 PERVASIVE PLAYERS 
             13.5.4 PARTICIPANTS 
             13.5.5 COMPANY FOOTPRINT
     13.6 START- UP/SME EVALUATION MATRIX 
             13.6.1 PROGRESSIVE COMPANIES 
             13.6.2 RESPONSIVE COMPANIES 
             13.6.3 DYNAMIC COMPANIES
             13.6.4 STARTING BLOCKS
             13.6.5 COMPETITIVE BENCHMARKING
     13.7 COMPETITIVE SCENARIO AND TRENDS 
             13.7.1 PRODUCT LAUNCHES
             13.7.2 DEALS
             13.7.3 OTHERS
14 COMPANY PROFILES 
     14.1 KEY PLAYERS 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             14.1.1 MERATIVE
             14.1.2 MCKESSON CORPORATION
             14.1.3 VERADIGM
             14.1.4 ATHENAHEALTH
             14.1.5 ORION HEALTH
             14.1.6 ORACLE CORPORATION
             14.1.7 GETWELLNETWORK, INC
             14.1.8 LINCOR SOLUTIONS
             14.1.9 COGNIZANT
             14.1.10 HARRIS HEALTHCARE
             14.1.11 GET REAL HEALTH
             14.1.12 ONEVIEW HEALTHCARE
             14.1.13 ADVANCEDMD
             14.1.14 EPIC SYSTEMS CORPORATION
             14.1.15 MEDITECH
     14.2 OTHER KEY PLAYERS 
             14.2.1 KAREO
             14.2.2 ECLINICAL WORKS
             14.2.3 WELLSTACK
             14.2.4 IQVIA
             14.2.5 VIVIFY HEALTH
             14.2.6 MEDHOST
             14.2.7 LUMA HEALTH INC.
             14.2.8 CUREMD HEALTHCARE
             14.2.9 MEDISYSINC.COM
             14.2.10 PATIENTPOINT, LLC
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
15 APPENDIX 
     15.1 DISCUSSION GUIDE 
     15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     15.3 AVAILABLE CUSTOMIZATIONS 
     15.4 RELATED REPORTS 
     15.5 AUTHOR DETAILS